Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,293 total articles
Charles H. Giancarlo, a director at Arista Networks, Inc. (NASDAQ:ANET), executed a sale of 8,000 shares on July 1, 2026, through a family trust. The transaction, valued at approximately $1,336,473, was conducted under a pre-established Rule 10b5-1 trading plan. This move occurs as Arista's stock trades near its 52-week high, supported by robust Q1…
Amar K. Goel, serving as both Chairman and Chief Innovation Officer at PubMatic, Inc. (NASDAQ:PUBM), executed a sale of 6,584 shares of the company’s Class A Common Stock on July 2, 2026. The transaction, valued at $89,861, was conducted through block trades at prices ranging from $13.50 to $13.89 per share, with a weighted average price of $13.648…
Jim Wassil, Chief Operating Officer at Vaxcyte, Inc. (NASDAQ: PCVX), executed a series of transactions on July 1, 2026, involving the sale of common stock and the exercise of stock options. The sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted in December 2025. Concurrently, the company reported structural changes to its bo…
Sheela Kosaraju, Senior Vice President and General Counsel at CIENA CORP (NASDAQ:CIEN), executed a sale of 2,013 shares of the company's common stock on July 1, 2026. The transaction was valued at $938,460, with each share sold at a price of $466.20. This sale was carried out under a Rule 10b5-1 trading plan that Ms. Kosaraju established on October…
Andrew Woods, PubMatic's General Counsel and Secretary, executed a transaction on July 2, 2026, resulting in the sale of 5,758 shares of the company's Class A Common Stock. The transaction, valued at $78,588, was classified as a "sell to cover" event designed to satisfy tax withholding obligations associated with the vesting of restricted stock uni…
PubMatic, Inc. (NASDAQ:PUBM) President of Engineering Kumar Mukul executed a sale of company shares on July 2, 2026, resulting in proceeds totaling $107,782. The transaction involved the liquidation of 7,897 shares of Class A Common Stock, with execution prices varying between $13.50 and $13.89 per share. This activity occurred against a backdrop o…
Paulina Klimenko, PubMatic's Chief Growth Officer, executed a series of share transactions in early July 2026, resulting in the sale of 23,923 shares for approximately $324,440. The transactions were structured to manage tax obligations on vested equity and adhere to pre-established trading plans. Concurrently, the company reported strong first-qua…
Marc D. Graff, Ciena Corporation’s Senior Vice President and Chief Financial Officer, executed a sale of 126 shares of common stock on July 1, 2026. The transaction, valued at $58,741, was conducted under a Rule 10b5-1 trading plan established earlier in the year. This sale occurs against a backdrop of substantial stock appreciation and significant…
Danijela Stojanovic, serving as the Interim Chief Financial Officer for Gemini Space Station, Inc. (NASDAQ: GEMI), executed a sale of company stock on July 2, 2026, following the vesting of restricted stock units. The transaction, valued at $37,464, was necessitated by tax withholding obligations rather than discretionary trading intent. This finan…
Indie Semiconductor, Inc. (NASDAQ: INDI) CFO Wu Naixi executed a $85,913 sale of 19,640 Class A common shares on July 2, 2026, to cover withholding taxes from RSU vesting. The transaction occurred under a Rule 10b5-1 plan established in December 2025, amidst a 23% weekly stock surge and significant corporate activity, including a €40 million acquis…
Michael Wittmann, Chief Operating Officer at indie Semiconductor, Inc. (NASDAQ: INDI), executed a sale of 30,207 shares of Class A Common Stock on July 2, 2026. The transaction, valued at approximately $134,460, was conducted at an average price of $4.4513 per share. This divestment was necessitated by the requirement to cover withholding taxes ass…
Jamie L. Reynoso, Chief Executive Officer of Medicare Advantage at Clover Health Investments Corp. (NASDAQ:CLOV), executed a sale of 6,229 Class A Common Stock shares on July 6, 2026. The transaction, valued at $32,764, was strictly structured to satisfy tax withholding requirements associated with the vesting of Restricted Stock Units (RSUs). This…
Frederick R. Wilson, a director at Etsy Inc. (NASDAQ: ETSY), has executed a series of stock sales totaling approximately $1.48 million on July 1, 2026. The transactions, which involved the disposal of 19,900 shares, were carried out under a Rule 10b5-1 trading plan established in February of this year. This insider activity occurs against a backdro…
Thomas Schiller, a director at Indie Semiconductor, Inc. (NASDAQ: INDI), executed a transaction involving the sale of company stock to satisfy tax liabilities arising from the vesting of restricted stock units. The sale occurred against a backdrop of recent financial reporting where the company missed earnings per share forecasts but slightly surpa…
Cardlytics Inc. (NASDAQ: CDLX) CEO Amit Gupta executed a series of stock sales totaling approximately $70,916 in early July, following the vesting of restricted stock units. The transactions coincide with the stock trading near its 52-week low of $4.25, amid ongoing discussions about the company's valuation and recent financial performance that sho…
Donald McClymont, CEO of Indie Semiconductor, Inc. (NASDAQ:INDI), executed a sale of 126,496 Class A common shares on July 2, 2026, totaling $563,071 at a price of $4.4513 per share. The transaction was necessitated by the vesting of restricted stock units (RSUs) on July 1, 2026, which granted him 243,750 shares, with the sale intended to cover wit…
Maurice Sciammas, Executive Vice President of Worldwide Sales and Marketing at Monolithic Power Systems Inc. (NASDAQ: MPWR), executed a stock sale on July 1, 2026, resulting in the disposal of 30 shares valued at $40,548. The transaction was facilitated through the Clement Sciammas Trust and adhered to a Rule 10b5-1 trading plan established on Nove…
Datadog, Inc. (NASDAQ: DDOG) director Michael Callahan has executed a significant sale of company stock, moving 12,500 Class A Common Shares on July 1, 2026. The transaction, valued at approximately $3.34 million, was conducted under a pre-arranged 10b5-1 trading plan established in March 2026. This sale follows a conversion of an equal number of C…
Recent Securities and Exchange Commission filings reveal that Kristina Burow, a ten percent owner of Boundless Bio, Inc. (NASDAQ:BOLD), executed a cashless stock option exercise resulting in the disposal of 16,000 shares on July 1, 2026. The transaction, valued at $39,840 based on a $2.49 per-share sale price, was completed alongside several other …
Clearfield, Inc. (NASDAQ: CLFD) Chief Executive Officer Cheryl Beranek executed a sale of 1,778 shares of the company's common stock on July 1, 2026. The transaction, valued at $71,226, was conducted under a pre-arranged Rule 10b5-1 trading plan adopted in December 2025. Following this divestment, Beranek retains direct ownership of 492,973 shares.…
Entities affiliated with ARCH Venture Funds reported the sale of 16,000 shares of Boundless Bio, Inc. (NASDAQ:BOLD) on July 1, 2026, totaling $39,840 in proceeds. The transaction involved a cashless exercise of fully vested stock options originally granted to board member Kristina Burow. The shares were initially acquired at $1.03 and immediately s…
John D. Couling, Senior Vice President of Entertainment at Dolby Laboratories, Inc. (NASDAQ:DLB), executed a significant stock transaction on July 1, 2026, selling 7,667 shares of the company's Class A Common Stock. The sale, valued at approximately $407,894, follows the immediate exercise of employee stock options for an identical number of shares…
Lynton Nicholas Hollmeyer, Cardlytics Inc.'s Chief Legal & Privacy Officer, executed a sale of 2,151 shares on July 2, 2026, valued at $9,453. The transaction was necessitated by tax withholding requirements following the vesting of restricted stock units. This activity occurs against a backdrop of stock price volatility and a recent quarterly earn…
Omada Health Inc. CEO Sean P. Duffy executed a series of stock transactions on July 1, 2026, selling 25,886 shares worth $587,222 under a pre-established 10b5-1 plan. The sale coincides with the company's Q1 2026 earnings beat, revenue growth of 42%, and recent board elections. Duffy simultaneously exercised stock options to acquire an equal number…
K. Charles Janac, President and Chief Executive Officer of Arteris, Inc. (NASDAQ:AIP), executed a series of stock transactions on July 2, 2026, totaling approximately $7.42 million. The transactions comprised both direct sales to cover tax liabilities and indirect dispositions through a pre-arranged trading plan. Despite the executive's sales, Arte…
